Translate Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 13th of September, 2021.
0 hedge funds and large institutions have $0 invested in Translate Bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 145 closing their positions.
2,500% more call options, than puts
Call options by funds: $104K | Put options by funds: $4K
100% less funds holding
Funds holding: 145 → 0 (-145)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $1.85B → $0 (-$1.85B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 145
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$494M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$294M |
| 3 |
BlackRock
New York
|
-$153M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$106M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$103M |
TBIO Hedge Fund Activity: Q3 2021 in Review
0 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2021, worth a combined $0 — down 100% from $1.85B a quarter earlier.
Sellers outnumbered buyers: 145 funds closed out of TBIO and 0 opened new positions — a net loss of 145 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Baupost Group, exiting entirely with an estimated $494M sold.
- 0 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2021, down from 145 in Q2 2021.
- Funds reported $0 of Translate Bio, Inc. Common Stock stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2021 and 145 closed out, a net change of -145 holders.
- The largest Translate Bio, Inc. Common Stock seller in Q3 2021 was Baupost Group, an estimated $494M sold.
Based on aggregated 13F filings for Q3 2021.